Print Page  |  Close Window

Overview

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 2,600 people across 36 countries.

MEDP (Common Stock)
$47.98
Change (%)  +0.88 (1.87%)
Volume 232,331
Date as of  07/20/18 4:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.
Stock chart for: MEDP.O.  Currently trading at $47.98 with a 52 week high of $47.36 and a 52 week low of $27.07.

Upcoming Events

Tuesday, July 31, 2018 9:00 a.m. ETQ2 2018 Medpace Holdings, Inc. Earnings Conference Call

View all events

Primary IR Contact

Medpace Holdings, Inc.
5375 Medpace Way
Cincinnati, OH 45227
Phone: +1.513.579.9911
investor@medpace.com